Alexander Spira, MD, PhD, FACP
Virginia Cancer Specialists Research Institute
Topic Presenter
Biography
Dr. Alexander Spira earned his medical degree from the New York University School of Medicine. He then went on to complete his internship and residency at the Hospital of the University of Pennsylvania, and his medical oncology fellowship at Johns Hopkins Hospital. During his training, Dr. Spira was granted many awards and honors, and he completed several specialized fellowship programs. Among these honors were the National Institutes of Health Medical Scientist Training Program Fellowship (1990-1997), Merck Corporation Scholarship (1995-1995), Pediatric AIDS Foundation Fellowship (1993- 1995) and Harvard University Scholarship (1987-1990). Dr. Spira has also received his PhD from the New York School of Arts and Sciences. As Director of the Virginia Cancer Specialists Research Institute and the Phase I Trial Program, Dr. Spira is actively involved in advancing medicine and offering targeted treatment options for patients. Although his research interests are numerous, Dr. Spira particularly enjoys studying immunotherapy, personalized medicine, GI, thoracic and lung cancer and sarcomas. Dr. Spira is Chief Scientific Officer of NEXT Oncology, as well as Co-Chair of the US Oncology Thoracic Oncology Committee, Chair of the US Oncology Research Executive Committee, and member of the US Oncology National Policy Board Executive Committee. Dr. Spira is a faculty member at Johns Hopkins School of Medicine and serves as Assistant Professor of Oncology. Throughout his career, Dr. Spira has been recognized as a Top Doctor in Northern Virginia Magazine and Washingtonian magazine for multiple years. In 2014, he received the prestigious “Castle Connolly America’s Top Doctor” award. In his spare time, Dr. Spira enjoys spending time with his family, coaching children’s sports, cycling, and cheering on his favorite New York sports teams.
Financial Disclosure
incyte
Consultant
Advisor
Amgen
Consultant
Advisor
Novartis
Consultant
Advisor
Mirati Therapeutics
Advisor
Consultant
Gritstone Oncology
Consultant
Advisor
Jazz Pharmaceuticals
Consultant
Advisor
Takeda
Consultant
Advisor
Janssen Research & Development
Advisor
Consultant
Mersana
Consultant
Advisor
Gritstone Bio
Consultant
Advisor
Daiichi Sankyo/Astra Zeneca
Advisor
Consultant
Regeneron
Advisor
Consultant
Lilly
Consultant
Advisor
Black Diamond Therapeutics
Advisor
Consultant
Sanofi
Consultant
Advisor
ArriVent Biopharma
Advisor
Consultant
Synthekine
Consultant
Advisor
GSK
Consultant
Advisor
Revolution Medicines
Consultant
Advisor
normunity
Consultant
Advisor
myricx
Consultant
Advisor
Summit Therapeutics
Consultant
Advisor
Tempus
Consultant
Advisor
AstraZeneca/MedImmune
Consultant
Advisor
Merck
Consultant
Advisor
Bristol-Myers Squibb
Consultant
Advisor
Blueprint Medicines
Consultant
Advisor
Verastem
Consultant
Advisor
NEXT Oncology Virginia
Employee
IQVIA
Ownership Interest